Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.14 - $3.43 $153,450 - $245,951
-71,706 Reduced 92.26%
6,017 $18,000
Q1 2022

May 16, 2022

SELL
$2.2 - $6.01 $738,590 - $2.02 Million
-335,723 Reduced 81.2%
77,723 $234,000
Q4 2021

Feb 14, 2022

SELL
$6.0 - $9.92 $519,324 - $858,615
-86,554 Reduced 17.31%
413,446 $2.66 Million
Q3 2021

Nov 15, 2021

BUY
$6.98 - $12.03 $3.49 Million - $6.02 Million
500,000 New
500,000 $3.54 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $371M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.